The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Open accessAbstract
CONTEXT: Severe sepsis is typically characterized by initial cytokine-mediated hyperinflammation. Whether this hyperinflammatory phase is followed by immunosuppression is controversial. Animal studies suggest that multiple immune defects occur in sepsis, but data from humans remain conflicting. OBJECTIVES: To determine the association of sepsis with changes in host innate and adaptive immunity and to examine potential mechanisms for putative immunosuppression. DESIGN, SETTING, AND PARTICIPANTS: Rapid postmortem spleen and lung tissue harvest was performed at the bedsides of 40 patients who died in intensive care units (ICUs) of academic medical centers with active severe sepsis to characterize their immune status at the time of death (2009-2011). Control spleens (n = 29) were obtained from patients who were declared brain-dead or had emergent splenectomy due to trauma; control lungs (n = 20) were obtained from transplant donors or from lung cancer resections. MAIN OUTCOME MEASURES: Cytokine secretion assays and immunophenotyping of cell surface receptor-ligand expression profiles were performed to identify potential mechanisms of immune dysfunction. Immunohistochemical staining was performed to evaluate the loss of immune effector cells. RESULTS: The mean ages of patients with sepsis and controls were 71.7 (SD, 15.9) and 52.7 (SD, 15.0) years, respectively. The median number of ICU days for patients with sepsis was 8 (range, 1-195 days), while control patients were in ICUs for 4 or fewer days. The median duration of sepsis was 4 days (range, 1-40 days). Compared with controls, anti-CD3/anti-CD28-stimulated splenocytes from sepsis patients had significant reductions in cytokine secretion at 5 hours: tumor necrosis factor, 5361 (95% CI, 3327-7485) pg/mL vs 418 (95% CI, 98-738) pg/mL; interferon γ, 1374 (95% CI, 550-2197) pg/mL vs 37.5 (95% CI, -5 to 80) pg/mL; interleukin 6, 3691 (95% CI, 2313-5070) vs 365 (95% CI, 87-642) pg/mL; and interleukin 10, 633 (95% CI, -269 to 1534) vs 58 (95% CI, -39 to 156) pg/mL; (P < .001 for all). There were similar reductions in 5-hour lipopolysaccharide-stimulated cytokine secretion. Cytokine secretion in sepsis patients was generally less than 10% that in controls, independent of age, duration of sepsis, corticosteroid use, and nutritional status. Although differences existed between spleen and lung, flow cytometric analysis showed increased expression of selected inhibitory receptors and ligands and expansion of suppressor cell populations in both organs. Unique differences in cellular inhibitory molecule expression existed in immune cells isolated from lungs of sepsis patients vs cancer patients and vs transplant donors. Immunohistochemical staining showed extensive depletion of splenic CD4, CD8, and HLA-DR cells and expression of ligands for inhibitory receptors on lung epithelial cells. CONCLUSIONS: Patients who die in the ICU following sepsis compared with patients who die of nonsepsis etiologies have biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression. Targeted immune-enhancing therapy may be a valid approach in selected patients with sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Self-citationRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., & Karl, I. E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00002 · Cited by 1,340
Self-citationHarmful molecular mechanisms in sepsis
Rittirsch, D., Flierl, M. A., & Ward, P. A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2402 · Cited by 1,202
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Cited by
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Self-citationThe immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Self-citationImmunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,442
Self-citationSepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Interleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
van der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
Advances in the understanding and treatment of sepsis-induced immunosuppression
Venet, F., & Monneret, G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.165 · Cited by 981
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
Davenport, E. E., Burnham, K. L., Radhakrishnan, J., Humburg, P., Hutton, P., Mills, T. C., Rautanen, A., Gordon, A. C., Garrard, C., Hill, A. V. S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00046-1 · Cited by 856
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Self-citationGentile, L. F., Cuenca, A. G., Efron, P. A., Ang, D., Bihorac, A., McKinley, B. A., Moldawer, L. L., & Moore, F. A. (2012) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e318256e000 · Cited by 801
The Pathogenesis of Sepsis and Potential Therapeutic Targets
Huang, M., Cai, S., & Su, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215376 · Cited by 776
Macrophage polarization in pathology
Sica, A., Erreni, M., Allavena, P., & Porta, C. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1995-y · Cited by 673
Sepsis: Current Dogma and New Perspectives
Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 677
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
Delano, M. J., & Ward, P. A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82224 · Cited by 644
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options
Liu, D., Huang, S.-Y., Sun, J.-H., Zhang, H.-C., Cai, Q.-L., Gao, C., Li, L., Cao, J., Xu, F., Zhou, Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00422-y · Cited by 607
The inflammatory response in sepsis
Bosmann, M., & Ward, P. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.09.004 · Cited by 558
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
van Vught, L. A., Klein Klouwenberg, P. M. C., Spitoni, C., Scicluna, B. P., Wiewel, M. A., Horn, J., Schultz, M. J., Nürnberg, P., Bonten, M. J. M., Cremer, O. L., et al. (2016) · JAMA · doi:10.1001/jama.2016.2691 · Cited by 528
Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis
Takasu, O., Gaut, J. P., Watanabe, E., To, K., Fagley, R. E., Sato, B., Jarman, S., Efimov, I. R., Janks, D. L., Srivastava, A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1983oc · Cited by 514
Self-citationPersistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
Drewry, A. M., Samra, N., Skrupky, L. P., Fuller, B. M., Compton, S. M., & Hotchkiss, R. S. (2014) · Shock · doi:10.1097/shk.0000000000000234 · Cited by 512
Self-citationSepsis—Pathophysiology and Therapeutic Concepts
Jarczak, D., Kluge, S., & Nierhaus, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.628302 · Cited by 453
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Francois, B., Jeannet, R., Daix, T., Walton, A. H., Shotwell, M. S., Unsinger, J., Monneret, G., Rimmelé, T., Blood, T., Morre, M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98960 · Cited by 431
Self-citationShalova, I. N., Lim, J. Y., Chittezhath, M., Zinkernagel, A. S., Beasley, F., Hernández-Jiménez, E., Toledano, V., Cubillos-Zapata, C., Rapisarda, A., Chen, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.001 · Cited by 419
Reactivation of Multiple Viruses in Patients with Sepsis
Walton, A. H., Muenzer, J. T., Rasche, D., Boomer, J. S., Sato, B., Brownstein, B. H., Pachot, A., Brooks, T. L., Deych, E., Shannon, W. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098819 · Cited by 411
Self-citationThe pathophysiology of sepsis and precision-medicine-based immunotherapy
Giamarellos-Bourboulis, E. J., Aschenbrenner, A. C., Bauer, M., Bock, C., Calandra, T., Gat-Viks, I., Kyriazopoulou, E., Lupse, M., Monneret, G., Pickkers, P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01660-5 · Cited by 374
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Qin, W., Hu, L., Zhang, X., Jiang, S., Li, J., Zhang, Z., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02298 · Cited by 369
Long-term cerebral consequences of sepsis
Widmann, C. N., & Heneka, M. T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70017-1 · Cited by 361
Sepsis-Induced Immunosuppression
Torres, L. K., Pickkers, P., & van der Poll, T. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040214 · Cited by 355
Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis
Cao, C., Yu, M., & Chai, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2015-1 · Cited by 354
Endothelial barrier dysfunction in septic shock
Opal, S. M., & van der Poll, T. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12331 · Cited by 353
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis
Weber, G. F., Chousterman, B. G., He, S., Fenn, A. M., Nairz, M., Anzai, A., Brenner, T., Uhle, F., Iwamoto, Y., Robbins, C. S., et al. (2015) · Science · doi:10.1126/science.aaa4268 · Cited by 350
Liu, T. F., Vachharajani, V. T., Yoza, B. K., & McCall, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362343 · Cited by 340
Neutrophil dysregulation during sepsis: an overview and update
Shen, X., Cao, K., Jiang, J., Guan, W., & Du, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13112 · Cited by 333
Immunopathophysiology of human sepsis
Wiersinga, W. J., & van der Poll, T. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104363 · Cited by 322
Molecular and epigenetic basis of macrophage polarized activation
Porta, C., Riboldi, E., Ippolito, A., & Sica, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.003 · Cited by 320
Sirtuins Link Inflammation and Metabolism
Vachharajani, V. T., Liu, T., Wang, X., Hoth, J. J., Yoza, B. K., & McCall, C. E. (2016) · Journal of Immunology Research · doi:10.1155/2016/8167273 · Cited by 320
The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Boomer, J. S., Green, J. M., & Hotchkiss, R. S. (2014) · Virulence · doi:10.4161/viru.26516 · Cited by 317
Self-citationMacrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective
Pérez, S., & Rius-Pérez, S. (2022) · Antioxidants · doi:10.3390/antiox11071394 · Cited by 312
“Cytokine storm is one of the main causes of the high mortality rate in sepsis because it generates an amplified and uncontrolled inflammatory response that leads to extensive tissue damage and multi-organ failure [16].”
BackgroundChang, K., Svabek, C., Vazquez-Guillamet, C., Sato, B., Rasche, D., Wilson, S., Robbins, P., Ulbrandt, N., Suzich, J., Green, J., et al. (2014) · Critical Care · doi:10.1186/cc13176 · Cited by 304
Self-citationThe role of neutrophils in immune dysfunction during severe inflammation
Leliefeld, P. H. C., Wessels, C. M., Leenen, L. P. H., Koenderman, L., & Pillay, J. (2016) · Critical Care · doi:10.1186/s13054-016-1250-4 · Cited by 298
Integrative Physiology of Pneumonia
Quinton, L. J., Walkey, A. J., & Mizgerd, J. P. (2018) · Physiological Reviews · doi:10.1152/physrev.00032.2017 · Cited by 295
Platelets in Sepsis: An Update on Experimental Models and Clinical Data
Assinger, A., Schrottmaier, W. C., Salzmann, M., & Rayes, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01687 · Cited by 283
Chang, K. C., Burnham, C.-A., Compton, S. M., Rasche, D. P., Mazuski, R., SMcDonough, J., Unsinger, J., Korman, A. J., Green, J. M., & Hotchkiss, R. S. (2013) · Critical Care · doi:10.1186/cc12711 · Cited by 281
Self-citationSurviving sepsis campaign: research priorities for sepsis and septic shock
Coopersmith, C. M., De Backer, D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martin-Loeches, I., Nunnally, M. E., Antonelli, M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5175-z · Cited by 281
Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock
Leligdowicz, A., Dodek, P. M., Norena, M., Wong, H., Kumar, A., & Kumar, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201310-1875oc · Cited by 274
Inflammatory and Immune Responses to Surgery and Their Clinical Impact
Alazawi, W., Pirmadjid, N., Lahiri, R., & Bhattacharya, S. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001691 · Cited by 274
The Search for Effective Therapy for Sepsis: Back to the Drawing Board?
Angus, D. C. (2011) · JAMA · doi:10.1001/jama.2011.1853 · Cited by 264
Martínez-García, J. J., Martínez-Banaclocha, H., Angosto-Bazarra, D., de Torre-Minguela, C., Baroja-Mazo, A., Alarcón-Vila, C., Martínez-Alarcón, L., Amores-Iniesta, J., Martín-Sánchez, F., Ercole, G. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10626-x · Cited by 233
SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition
Sattler, A., Angermair, S., Stockmann, H., Heim, K. M., Khadzhynov, D., Treskatsch, S., Halleck, F., Kreis, M. E., & Kotsch, K. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140965 · Cited by 196
Cytokine removal in human septic shock: Where are we and where are we going?
Honore, P. M., Hoste, E., Molnár, Z., Jacobs, R., Joannes-Boyau, O., Malbrain, M. L. N. G., & Forni, L. G. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0530-y · Cited by 192
Blood Purification and Mortality in Sepsis: A Meta-Analysis of Randomized Trials*
Zhou, F., Peng, Z., Murugan, R., & Kellum, J. A. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828cf412 · Cited by 189
Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges
Shankar-Hari, M., & Rubenfeld, G. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0544-7 · Cited by 180
Li, Y., Zhang, P., Wang, C., Han, C., Meng, J., Liu, X., Xu, S., Li, N., Wang, Q., Shi, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454538 · Cited by 177
Horiguchi, H., Loftus, T. J., Hawkins, R. B., Raymond, S. L., Stortz, J. A., Hollen, M. K., Weiss, B. P., Miller, E. S., Bihorac, A., Larson, S. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00595 · Cited by 164
The intestinal microbiota and host immune interactions in the critically ill
Schuijt, T. J., van der Poll, T., de Vos, W. M., & Wiersinga, W. J. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.02.001 · Cited by 123
Huang, T.-S., Shyu, Y.-C., Chen, H.-Y., Lin, L.-M., Lo, C.-Y., Yuan, S.-S., & Chen, P.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054431 · Cited by 108
The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis
Kanczkowski, W., Sue, M., Zacharowski, K., Reincke, M., & Bornstein, S. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.019 · Cited by 101
Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study
Shankar-Hari, M., Datta, D., Wilson, J., Assi, V., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A., Felton, J. M., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5389-0 · Cited by 74
Bridging translation for acute kidney injury with better preclinical modeling of human disease
Skrypnyk, N. I., Siskind, L. J., Faubel, S., & de Caestecker, M. P. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00552.2015 · Cited by 61
Arguing for Adaptive Clinical Trials in Sepsis
Talisa, V. B., Yende, S., Seymour, C. W., & Angus, D. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01502 · Cited by 52
Immune response in bacterial and Candida sepsis
Patricio, P., Paiva, J. A., & Borrego, L. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00011 · Cited by 42
Hung, K.-Y., Chen, Y.-M., Wang, C.-C., Wang, Y.-H., Lin, C.-Y., Chang, Y.-T., Huang, K.-T., Lin, M.-C., & Fang, W.-F. (2019) · Nutrients · doi:10.3390/nu11020367 · Cited by 34
Chen, W., Huang, N.-T., Li, X., Yu, Z. T. F., Kurabayashi, K., & Fu, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00098 · Cited by 31
Sepsis and the diverse organ-gastrointestinal tract axis
Wang, J. D. J., Suan, E., Li, S. S., & Shelat, V. G. (2025) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v14.i4.105547 · Cited by 12
Towards personalized medicine in sepsis: quest for Shangri-La?
Sen, A., & Yende, S. (2013) · Critical Care · doi:10.1186/cc12485 · Cited by 11
“Boomer and colleagues [14] conducted a compre hensive assessment of immune dysfunction in human subjects who died of sepsis and multi-organ failure.”
Which Nutritional Regimen for the Comorbid Complex Intensive Care Unit Patient?
Singer, P., Weinberger, H., & Tadmor, B. (2013) · World Review of Nutrition and Dietetics · doi:10.1159/000341294 · Cited by 9
Metadata
- Authors
- Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., Srivastava, A., Swanson, P. E., Green, J. M., & Hotchkiss, R. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-12-21
- Volume
- 306
- Issue
- 23
- Pages
- 2594
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1998427452
- Cited by
- 1,781
- References
- 49
- FWCI
- 52.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.